Immunobiology of vasoactive intestinal peptide (VIP) (Q33818689)

29 July 2017

1 reference

title

Immunobiology of vasoactive intestinal peptide (VIP) (English)

1 reference

29 July 2017

Pozo D

1 reference

29 July 2017

Delgado M

1 reference

29 July 2017

Martínez M

1 reference

29 July 2017

Guerrero JM

1 reference

29 July 2017

Leceta J

1 reference

29 July 2017

Gomariz RP

1 reference

29 July 2017

Calvo JR

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

7-11

1 reference

The syntax of immune-neuroendocrine communication

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Polypeptide with Broad Biological Activity: Isolation from Small Intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Release of vasoactive intestinal polypeptide in mast cells by histamine liberators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Regulation of VIP production and secretion by murine lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Gene expression of VIP receptor in rat lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Vasoactive intestinal peptide regulation of granulomatous inflammation in murine Schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

VIP as a modulator of lung inflammation and airway constriction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

Chronic inflammation caused by lymphotoxin is lymphoid neogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901525-X

7 January 2021

10.1016/S0167-5699(99)01525-X

Identifiers

DOI

1 reference

29 July 2017

1 reference